Manufacturer copay assistance · Rybrevant (J9061) · Janssen
$5 · Maximum benefit $26,000/year · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Rybrevant — check the full fund board.
Yes — Janssen CarePath Savings Program from Janssen. $5. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$5 Maximum benefit: $26,000/year. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government. Income limit: No income requirement.